市場調査報告書：世界の眼科手術、装置、薬剤市場

Abstract

This report details worldwide the incidence and prevalence by country/region of vision disorders (myopia, hyperopia, presbyopia, glaucoma, cataracts and retinal disease), and details the current and projected market for diagnostic and therapeutic products in the management of these vision disorders, including general vision diagnostics, diagnostics for glaucoma, corneal and retinal disorders, and therapeutic options for these disorders including use of pharmaceuticals, surgery and devices. The report details current products and technologies in use and the status of development of novel products under development. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor share data are presented for the U.S., individual western European countries (UK, Germany, France, BeNeLux, Italy and Spain), Japan and other key international markets; Asia (India, Korea, Australia, Russia and China), the Americas (Canada, Mexico, Brazil) and Middle East and Africa categories. The report profiles a minimum of 100 companies, with equitable inclusion or exclusion of specific companies based on consistent criteria. The company profiles provide detailed information on 10-15 major competitors, and brief profiles of companies with less sizeable current or potential positions in the market and additional profiles of companies with noteworthy novel or advanced research activities in the market.

The report establishes the market size for key international markets (as indicated above) for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market (shifts in share based on technology) as technologies gain or lose relative market performance over this period.

EXECUTIVE SUMMARY

Ophthalmology Background & Market Segments

Vision Diagnostics
Eye Care Products
Cataract Surgery
Refractive Surgery
Glaucoma
Back of Eye

The Ophthalmology Pharmaceutical Market

The Ophthalmic Device Market

Section 1: About vision care

1.1 The Eye Care Specialist: Optometrists & Ophthalmologists
1.2 Diagnostic Map for Ocular Conditions
1.3 Diseases of the Eye and Vision Conditions
- 1.3.1 Conditions of the Cornea
- 1.3.2 Cornea Disease Diagnostics
  - 1.3.2.1 Visual Acuity and General Vision Diagnostics
- 1.3.3 Glaucoma
  - 1.3.3.1 Glaucoma Diagnostics
- 1.3.4 Cataracts
  - 1.3.4.1 Cataract Diagnostics
- 1.3.5 Back of Eye Disorders
  - 1.3.5.1 Retinal Diagnostics

Section 2: THE MARKET FOR DIAGNOSTIC INSTRUMENTATION

2.1 Market Overview: Diagnostic Devices
- 2.1.1 Hand-held Instruments
- 2.1.2 Diagnostic Equipment

Section 3: THERAPEUTIC OPTIONS

3.1 Vision Correction Options
- 3.1.1 Corrective Lenses
  - 3.1.1.1 Eyeglasses--The Old Standby
- 3.1.2 Contact Lenses
- 3.1.3 Orthokeratology
- 3.1.4 Corneal Ring Segments
- 3.1.5 Refractive Surgery
  - 3.1.5.1 LASIK
  - 3.1.5.2 Custom LASIK (Wavefront-Guided Laser Surgery)
  - 3.1.5.3 Conductive Keratoplasty (CK)
  - 3.1.5.4 Laser Epithelial Keratomileusis (LASEK)
  - 3.1.5.5 PHAKIC IOLs
  - 3.1.5.6 Photorefractive Keratectomy (PRK)
  - 3.1.5.7 Laser Thermal Keratoplasty (LTK)
3.2 Glaucoma Treatment Approaches
- 3.2.1 Pharmaceutical therapy
- 3.2.2 Interventional Therapy
3.3 Cornea Diseases and Treatment Options
- 3.3.1 Allergies
- 3.3.2 Conjunctivitis (Pink Eye)
- 3.3.3 Corneal Infections
- 3.3.4 Dry Eye
- 3.3.5 Corneal Dystrophies
  - 3.3.5.1 Fuchs' Dystrophy
  - 3.3.5.2 Keratoconus
  - 3.3.5.3 Corneal Transplants
  - 3.3.5.4 Lattice Dystrophy
  - 3.3.5.5 Map-dot-fingerprint Dystrophy
- 3.3.6 Ocular Herpes
- 3.3.7 Herpes Zoster (Shingles)
- 3.3.8 Pterygium
- 3.3.9 Stevens-Johnson Syndrome
3.4 Cataract Treatment Options
- 3.4.1 Cataract Surgery
  - 3.4.1.1 Phacoemulsification
  - 3.4.1.2 Hand-held Instruments
  - 3.4.1.3 Intraocular Lenses (IOLs)
3.5 Back of the Eye Disease and Treatment Options
- 3.5.1 Macular Degeneration
  - 3.5.1.1 Wet and Dry Forms of Macular Degeneration
  - 3.5.1.2 Retinal Detachment
- 3.5.2 Treatment of Retinal Detachments
  - 3.5.2.1 Laser Photocoagulation
  - 3.5.2.2 Cryopexy
  - 3.5.2.3 Pneumatic Retinopexy
  - 3.5.2.4 Scleral Buckle
  - 3.5.2.5 Pharmaceutical Treatments for Wet AMD

Section 4: Incidence/Prevalence of Ophthalmic Disorders

4.1 Worldwide Incidence and Prevalence of Vision Disorders
- 4.1.1 The Americas: Vision Disorders
- 4.1.2 The Americas: Keratoconus
- 4.1.3 Europe
  - 4.1.3.1 Vision Disorders: Europe
  - 4.1.3.2 Keratoconus: Europe
- 4.1.4 Asia/Pacific
  - 4.1.4.1 Vision Disorders: Asia/Pacific
  - 4.1.4.2 Keratoconus: Asia/Pacific
- 4.1.5 Middle East and Africa
  - 4.1.5.1 Vision Disorders: Middle East & Africa
  - 4.1.5.2 Keratoconus: Middle East & Africa
4.2 Worldwide Incidence and Prevalence of Glaucoma
- 4.2.1 The Americas
- 4.2.2 Europe
- 4.2.3 Asia/Pacific
- 4.2.4 Middle East and Africa
4.3 Cataracts
- 4.3.1 Cataracts: The Americas
- 4.3.2 Cataracts: Europe
- 4.3.3 Cataracts: Asia/Pacific
- 4.3.4 Cataracts: Middle East & Africa
4.4 Retinal Disease
- 4.4.1 Retinal Disease: The Americas
- 4.4.2 Retinal Disease: Europe
- 4.4.3 Retinal Disease: Asia/Pacific
- 4.4.4 Retinal Disease: Middle East & Africa

Section 5: THE MARKET FOR OPHTHALMOLOGY PRODUCTS

5.1 Demand for Products and Services
5.2 Global Market for Ophthalmic Products
- 5.2.1 Refractive Surgery
  - 5.2.1.1 Microkeratomes
  - 5.2.1.2 Flap Cutting Lasers
  - 5.2.1.3 Ablation Lasers
  - 5.2.1.4 Glaucoma
  - 5.2.1.5 Cataract
  - 5.2.1.6 Phacoemusification
  - 5.2.1.7 Hand-held Instruments
- 5.2.2 Implantable Devices
  - 5.2.2.1 IOLs
  - 5.2.2.2 Back of Eye
5.3 Global Market for Ophthalmic Diagnostic Equipment
- 5.3.1 Ophthalmic Diagnostic Instrument Market, Americas
  - 5.3.1.1 USA: Ophthalmic Diagnostic Instrument Market
  - 5.3.1.2 USA: Ophthalmic Diagnostic Instrument Market Share (%) by Company
  - 5.3.1.3 Non-USA Americas: Ophthalmic Diagnostic Instrument Market
  - 5.3.1.4 Non-USA Americas: Diagnostic Instrument Market Share (%) by Company
- 5.3.2 Ophthalmic Diagnostic Instrument Market, Europe
  - 5.3.2.1 UNITED KINGDOM: Ophthalmic Diagnostic Instrument Market
  - 5.3.2.2 UNITED KINGDOM: Ophthalmic Diagnostic Instrument Market Share (%) by Company
  - 5.3.2.3 GERMANY: Ophthalmic Diagnostic Instrument Market
  - 5.3.2.4 GERMANY: Ophthalmic Diagnostic Market Share (%) by Company
  - 5.3.2.5 FRANCE: Ophthalmic Diagnostic Market Share (%) by Company
  - 5.3.2.6 BENELUX: Ophthalmic Diagnostic Instrument Market
  - 5.3.2.7 BENELUX: Ophthalmic Diagnostic Market Share (%) by Company
  - 5.3.2.8 ITALY: Ophthalmic Diagnostic Instrument Market
  - 5.3.2.9 ITALY: Ophthalmic Diagnostic Market Share (%) by Company
  - 5.3.2.10 SPAIN: Ophthalmic Diagnostic Instrument Market
  - 5.3.2.11 SPAIN: Diagnostic Market Share (%) by Company
  - 5.3.2.12 EUROPE: Ophthalmic Diagnostic Instrument Market
- 5.3.3 Ophthalmic Diagnostic Instrument Market, Asia-Pacific
  - 5.3.3.1 JAPAN: Ophthalmic Diagnostic Instrument Market
  - 5.3.3.2 JAPAN: Ophthalmic Diagnostic Market Share (%) by Company
  - 5.3.3.3 Non-Japan ASIA-PACIFIC: Ophthalmic Diagnostic Instrument Market
  - 5.3.3.4 Non-Japan ASIA-PACIFIC: Ophthalmic Diagnostic Market Share (%) by Company
  - 5.3.3.5 TOTAL Asia Pacific: Ophthalmic Diagnostic Instrument Market
- 5.3.4 Worldwide: Ophthalmic Diagnostic Instrument Market by Company
5.4 Global Market for Cataract Surgery
- 5.4.1 Cataract Surgery Market, Americas
  - 5.4.1.1 USA Cataract Surgery Market
  - 5.4.1.2 USA: Cataract Surgery Market Share (%) by Company
  - 5.4.1.3 Non-USA Americas: Cataract Surgery Market
  - 5.4.1.4 Non-USA Americas: Cataract Surgery Market Share (%) by Company
  - 5.4.1.5 AMERICAS: Total Cataract Surgery Market ($Millions) by Company
- 5.4.2 Cataract Surgery Market, Europe
  - 5.4.2.1 UNITED KINGDOM: Cataract Surgery Market
  - 5.4.2.2 UNITED KINGDOM: Cataract Surgery Market Share (%) by Company
  - 5.4.2.3 GERMANY: Cataract Surgery Market
  - 5.4.2.4 GERMANY: Cataract Surgery Market Share (%) by Company
  - 5.4.2.5 FRANCE: Cataract Surgery Market
  - 5.4.2.6 FRANCE: Cataract Surgery Market Share (%) by Company
  - 5.4.2.7 BENELUX Cataract Surgery Market
  - 5.4.2.8 BENELUX: Cataract Surgery Market Share (%) by Company
  - 5.4.2.9 ITALY Cataract Surgery Market
  - 5.4.2.10 ITALY: Cataract Surgery Market Share (%) by Company
  - 5.4.2.11 SPAIN Cataract Surgery Market
  - 5.4.2.12 SPAIN: Cataract Surgery Market Share (%) by Company
  - 5.4.2.13 EUROPE, Cataract Surgery Product Revenues By Company
- 5.4.3 Cataract Surgery Market, Asia-Pacific
  - 5.4.3.1 JAPAN Cataract Surgery Market
  - 5.4.3.2 JAPAN: Cataract Surgery Market Share (%) by Company
  - 5.4.3.3 Non-Japan ASIA-PACIFIC: Cataract Surgery Market
  - 5.4.3.4 Non-Japan ASIA-PACIFIC: Cataract Surgery Market Share (%) by Company
  - 5.4.3.5 TOTAL Asia Pacific: Cataract Surgery Market Revenues ($Millions US) by Company
- 5.4.4 Worldwide: Cataract Surgery Market by Company
5.5 Global Market for Refractive Surgery
- 5.5.1 Refractive Surgery Market, Americas
  - 5.5.1.1 U.S. Refractive Surgery Market
  - 5.5.1.2 U.S. Refractive Surgery Market Share (%) by Company
  - 5.5.1.3 Non-USA Americas: Refractive Surgery Market
  - 5.5.1.4 Non-USA Americas: Refractive Surgery Market Share (%) by Company
  - 5.5.1.5 AMERICAS: Total Refractive Surgery Revenues by Company
- 5.5.2 Refractive Surgery Market, Europe
  - 5.5.2.1 UNITED KINGDOM: Refractive Surgery Market
  - 5.5.2.2 UNITED KINGDOM: Refractive Surgery Market Share (%) by Company
  - 5.5.2.3 GERMANY: Refractive Surgery Market
  - 5.5.2.4 GERMANY: Refractive Surgery Market Share (%) by Company
  - 5.5.2.5 FRANCE: Refractive Surgery Market
  - 5.5.2.6 FRANCE: Refractive Surgery Market Share (%) by Company
  - 5.5.2.7 BENELUX: Refractive Surgery Market
  - 5.5.2.8 BENELUX: Refractive Surgery Market Share (%) by Company
  - 5.5.2.9 ITALY: Refractive Surgery Market
  - 5.5.2.10 ITALY: Refractive Surgery Market Share (%) by Company
  - 5.5.2.11 SPAIN: Refractive Surgery Market
  - 5.5.2.12 SPAIN: Refractive Surgery Market Share (%) by Company
  - 5.5.2.13 EUROPE: Refractive Surgery Market by Company
- 5.5.3 Refractive Surgery Market, Asia-Pacific
  - 5.5.3.1 JAPAN: Refractive Surgery Market by Company
  - 5.5.3.2 JAPAN: Refractive Market Share (%) by Company
  - 5.5.3.3 Non-Japan ASIA-PACIFIC: Refractive Surgery Market by Country
  - 5.5.3.4 Non-Japan ASIA-PACIFIC: Refractive Market Share (%) by Company
  - 5.5.3.5 TOTAL Asia Pacific: Refractive Market by Company
- 5.5.4 Worldwide: Refractive Surgery Market by Company
5.6 Global Market for Ophthalmic Pharmaceuticals
- 5.6.1 Ophthalmic Pharmaceuticals Market, Americas
  - 5.6.1.1 U.S. Ophthalmic Pharmaceutical Market
  - 5.6.1.2 U.S. Ophthalmic Pharmaceutical Market Share (%) by Company
  - 5.6.1.3 U.S. Ophthalmic Pharmaceutical Market by Segment
  - 5.6.1.4 Non-USA Americas: Ophthalmic Pharmaceutical Market
  - 5.6.1.5 Non-USA Americas: Ophthalmic Pharmaceutical Market Share (%) by Company
  - 5.6.1.6 Non-USA Americas: Ophthalmic Pharmaceutical Market by Segment
  - 5.6.1.7 AMERICAS: Ophthalmic Pharmaceutical Market by Segment
- 5.6.2 Ophthalmic Pharmaceuticals Market, Europe
  - 5.6.2.1 UNITED KINGDOM: Ophthalmic Pharmaceutical Market
  - 5.6.2.2 UNITED KINGDOM: Ophthalmic Pharmaceutical Market Share (%) by Company
  - 5.6.2.3 GERMANY: Ophthalmic Pharmaceutical Market
  - 5.6.2.4 GERMANY: Ophthalmic Pharmaceutical Market Share (%) by Company
  - 5.6.2.5 FRANCE: Ophthalmic Diagnostic Instrument Market
  - 5.6.2.6 FRANCE: Ophthalmic Pharmaceutical Market
  - 5.6.2.7 FRANCE: Ophthalmic Pharmaceutical Market Share (%) by Company
  - 5.6.2.8 BENELUX: Ophthalmic Pharmaceutical Market
  - 5.6.2.9 BENELUX: Ophthalmic Pharmaceutical Market Share (%) by Company
  - 5.6.2.10 ITALY: Ophthalmic Pharmaceutical Market
  - 5.6.2.11 ITALY: Ophthalmic Pharmaceutical Market Share (%) by Company
  - 5.6.2.12 SPAIN: Ophthalmic Pharmaceutical Market
  - 5.6.2.13 SPAIN: Ophthalmic Pharmaceutical Market Share (%) by Company
  - 5.6.2.14 EUROPE: Ophthalmic Pharmaceutical Market by Company
  - 5.6.2.15 EUROPE: Ophthalmic Pharmaceutical Market by Segment
- 5.6.3 Ophthalmic Pharmaceuticals Market, Asia-Pacific
  - 5.6.3.1 JAPAN: Ophthalmic Pharmaceutical Market by Company
  - 5.6.3.2 JAPAN: Ophthalmic Pharmaceutical Market Share (%) by Company
  - 5.6.3.3 Non-Japan ASIA-PACIFIC: Ophthalmic Pharmaceutical Market by Company
  - 5.6.3.4 Non-Japan ASIA-PACIFIC: Ophthalmic Pharmaceutical Market Share (%) by Company
  - 5.6.3.5 TOTAL Asia Pacific: Ophthalmic Pharmaceutical Market by Company
  - 5.6.3.6 TOTAL Asia Pacific: Ophthalmic Pharmaceutical Market by Segment
- 5.6.4 Worldwide: Ophthalmic Pharmaceutical Market
  - 5.6.4.1 Worldwide: Ophthalmic Pharmaceutical Market by Company
  - 5.6.4.2 Worldwide: Ophthalmic Pharmaceutical Market by Segment

Section 6: Company Profiles

6.1 Leading Companies
- 6.1.1 Advanced Medical Optics
  - 6.1.1.1 Overview
  - 6.1.1.2 Products
  - 6.1.1.3 Pipeline
  - 6.1.1.4 Financials
- 6.1.2 Alcon Laboratories, Inc.
  - 6.1.2.1 Overview
- 6.1.3 Allergan
  - 6.1.3.1 Overview
  - 6.1.3.2 Products
  - 6.1.3.3 Pipeline
  - 6.1.3.4 Financials
- 6.1.4 Bausch & Lomb
  - 6.1.4.1 Overview
  - 6.1.4.2 Products
  - 6.1.4.3 Pipeline
  - 6.1.4.4 Financials
- 6.1.5 Carl Zeiss Meditech
  - 6.1.5.1 Overview
  - 6.1.5.2 Products
  - 6.1.5.3 Pipeline
  - 6.1.5.4 Financials
- 6.1.6 IntraLase, Inc.
  - 6.1.6.1 Overview
  - 6.1.6.2 Products
  - 6.1.6.3 Pipeline
  - 6.1.6.4 Financials
- 6.1.7 STAAR Surgical
  - 6.1.7.1 Overview
  - 6.1.7.2 Products
  - 6.1.7.3 Pipeline
  - 6.1.7.4 Financials
- 6.1.8 Iridex Corporation
  - 6.1.8.1 Overview
  - 6.1.8.2 Products
  - 6.1.8.3 Pipeline
  - 6.1.8.4 Financials
6.2 Other Companies
- 6.2.1 Acufocus
- 6.2.2 Addition Technology, Inc.
- 6.2.3 Advanced Cell Tech, Inc.
- 6.2.4 American Optisurgical, Inc. (AOI)
- 6.2.5 Aquasys, Inc
- 6.2.6 BD Medical Ophthalmic
- 6.2.7 Biosyntrx, Inc.
- 6.2.8 Calhoun Vision
- 6.2.9 CustomVis
- 6.2.10 Eagle Vision
- 6.2.11 Eli Lilly
- 6.2.12 Endo Optiks, Inc.
- 6.2.13 Escalon Medical Imaging
- 6.2.14 EyeKon Medical
- 6.2.15 Eyemaginations
- 6.2.16 Eyeonics, Inc.
- 6.2.17 EyeSys Vision, Inc.
- 6.2.18 FCI Ophthalmics
- 6.2.19 Genentech
- 6.2.20 Geuder AG
- 6.2.21 Glaukos
- 6.2.22 Haag-Streit
- 6.2.23 Heidelberg Engineering, Inc.
- 6.2.24 Heine
- 6.2.25 Howard Instruments
- 6.2.26 Huvitz
- 6.2.27 IOP, Inc.
- 6.2.28 IRIDEX
- 6.2.29 iScience Interventional
- 6.2.30 ISTA Pharmaceuticals
- 6.2.31 Keeler Instruments
- 6.2.32 Kowa Optimed
- 6.2.33 Lacrimedics
- 6.2.34 Leica Microsystems
- 6.2.35 Lenstec Inc
- 6.2.36 Lumenis
- 6.2.37 MacuScope
- 6.2.38 MacuSight, Inc.
- 6.2.39 Marco
- 6.2.40 Mastel Precision
- 6.2.41 Medennium
- 6.2.42 Micro Medical Devices, Inc
- 6.2.43 Moeller-Wedel.
- 6.2.44 MST
- 6.2.45 Neitz Instruments Co
- 6.2.46 NeoMedix
- 6.2.47 NeoVista
- 6.2.48 New World Medical
- 6.2.49 Nidek, Inc.
- 6.2.50 Novadaq Technologies
- 6.2.51 Novartis Ophthalmics
- 6.2.52 NovaVision Inc.
- 6.2.53 OASIS Medical
- 6.2.54 OccuLogix
- 6.2.55 OculusGen Biomedical
- 6.2.56 Odyssey Medical
- 6.2.57 Omni Lens
- 6.2.58 Ophtec
- 6.2.59 Optikon 2000 s.p.a.
- 6.2.60 Optimedica
- 6.2.61 Optos, Inc.
- 6.2.62 Optovue.
- 6.2.63 Pelion Surgical
- 6.2.64 Pfizer Ophthalmics
- 6.2.65 Quest Medical
- 6.2.66 Refractec
- 6.2.67 Reichert
- 6.2.68 Regeneron Pharmaceuticals
- 6.2.69 Rhein Medical
- 6.2.70 Santen, Inc.
- 6.2.71 Scan Optics
- 6.2.72 Schwind Eye-tech Solutions
- 6.2.73 ScyFIX
- 6.2.74 Second Sight
- 6.2.75 Sirion Holdings, Inc. (formerly Sirion Therapeutics)
- 6.2.76 Sonogage
- 6.2.77 Sonomed.
- 6.2.78 Stereo Optical Company, Inc.
- 6.2.79 STAAR Surgical
- 6.2.80 Surmodics
- 6.2.81 Synemed
- 6.2.82 Tekia
- 6.2.83 Titan Surgical
- 6.2.84 Tomey
- 6.2.85 Topcon Medical Systems (TMS)
- 6.2.86 Tracey Technologies
- 6.2.87 Trevi Technology
- 6.2.88 Visiogen, Inc.
- 6.2.89 Vistakon
- 6.2.90 Vistakon Pharmaceuticals, LLC
- 6.2.91 Visual Pathways
- 6.2.92 WaveLight AG
- 6.2.93 Welch Allyn
- 6.2.94 Woodlyn, Inc.
- 6.2.95 Ziemer Ophthalmic Systems AG.

Appendix: Company Addresses

APPENDIX A: Worldwide Prevalence of Vision Disorders
APPENDIX B: Worldwide Prevalence of Keratoconus
APPENDIX C: Worldwide Prevalence of Glaucoma
APPENDIX D: Worldwide Prevalence of Cataracts
APPENDIX E: Worldwide Prevalence of Back of Eye Disorders

Exhibit ES-1: Total Ophthalmic Products Market by Segment, 2006
Exhibit ES-2: Ophthalmic Product Revenues (Diagnostics, Surgical, Pharmaceuticals) by Country/Region

Exhibit 1-1: Optometrist Practice by Type
Exhibit 1-2: Ophthalmologists by Sub-Specialty
Exhibit 1-3: Practicing Ophthalmologists by Type of Practice/Role
Exhibit 1-4: Ophthalmologists by Practice Type
Exhibit 1-5: Cross-Sectional Schematic of the Human Eye
Exhibit 1-6: Snellen Eye Chart

Exhibit 2-1: Hand-Held Instrument Category Offerings, by Manufacturer
Exhibit 2-2: Diagnostic Equipment Used by the Eye Care Professional and Average Selling Prices
Exhibit 2-3: Worldwide Diagnostic Instrumentation Revenue, U.S. and Non-U.S., by Segment, 2006
Exhibit 2-4: Diagnostic Instrumentation Offerings, By Manufacturer
Exhibit 2-5: Percent of Ophthalmic Diagnostic Equipment Sold to O.D. vs M.D. in US vs International (OUS) Markets

Exhibit 3-1: Manufacturers of Corneal Reshaping Lenses
Exhibit 3-2: Manufacturers of Implantable Corneal Ring Segment Products for Vision Correction
Exhibit 3-3: LASIK Products and Manufacturers
Exhibit 3-4: Products Used in Custom Ablation LASIK
Exhibit 3-5: Phakic IOL Manufacturers and Products
Exhibit 3-6: Products for Non-LASIK Refractive Surgery Procedures
Exhibit 3-7: Open-Angle Glaucoma Prevalence Rates by Age and Race
Exhibit 3-8: Share of U.S. Glaucoma Medication Sales by Type, 2005
Exhibit 3-9: Glaucoma Pharmaceutical Products
Exhibit 3-10: Medical Device Products for the Treatment of Glaucoma
Exhibit 3-11: U.S. Glaucoma Treatment Procedures by Type, 2006
Exhibit 3-12: Pharmaceutical Allergy Medications
Exhibit 3-13: Anti-Infective and Anti-Inflammatory Ophthalmic Pharmaceutical Products
Exhibit 3-14: Products for the Treatment of Dry Eye
Exhibit 3-15: Ophthalmic Drugs by Type, 2004 & 2008
Exhibit 3-16: Phacoemulsification Systems for Cataract Surgery, U.S. and Rest of World, 2006
Exhibit 3-17: Phacoemulsification Equipment and Accessories
Exhibit 3-18: Conventional Intraocular Lens Manufacturers and Products
Exhibit 3-19: IOL Accessory Manufacturers and Products
Exhibit 3-20: Cataract Surgery Procedures, U.S. and Worldwide, 2003-2008
Exhibit 3-21: Multifocal IOL Manufacturers and Products
Exhibit 3-22: Phakic IOL Products and Manufacturers
Exhibit 3-23: Pharmaceuticals to Treat Age-related Macular Degeneration
Exhibit 3-24: Alternatives to Pharmaceutical Developments for the Treatment of Wet AMD
Exhibit 3-25: Manufacturers of Equipment for the Treatment of Retinal Disorders

Exhibit 4-1: The Americas, Prevalence of Vision Disorders
Exhibit 4-2: The Americas, Prevalence of Keratoconus
Exhibit 4-3: Europe, Prevalence of Vision Disorders
Exhibit 4-4: Europe, Prevalence of Keratoconus, by Country
Exhibit 4-5: Asia-Pacific, Prevalence of Vision Disorders
Exhibit 4-6: Asia-Pacific, Prevalence of Keratoconus
Exhibit 4-7: Middle East & Africa, Prevalence of Vision Disorders
Exhibit 4-8: Middle East & Africa, Prevalence of Keratoconus
Exhibit 4-9: U.S., Glaucoma Prevalence by Age
Exhibit 4-10: The Americas, Prevalence of Diagnosed and Undiagnosed Glaucoma, by Country
Exhibit 4-11: Europe, Glaucoma Prevalence, by Country
Exhibit 4-12: Asia-Pacific, Glaucoma Prevalence, by Country
Exhibit 4-13: Middle East & Africa, Glaucoma Prevalence, by Country
Exhibit 4-14: The Americas, Cataract Prevalence by Age
Exhibit 4-15: The Americas, Cataract Prevalence, by Country
Exhibit 4-16: Europe, Cataract Prevalence, by Country
Exhibit 4-17: Asia-Pacific, Cataract Prevalence, by Country
Exhibit 4-18: Middle East & Africa, Cataract Prevalence, by Country
Exhibit 4-19: The America, Prevalence of Diabetic Retinopathy Among Adults
Exhibit 4-20: The Americas, Age-Related Macular Degeneration Prevalence by Age and Type
Exhibit 4-21: Europe, Prevalence of Retinal Disease, by Country
Exhibit 4-22: Asia-Pacific, Prevalence of Retinal Disease, by Country
Exhibit 4-23: Middle East & Africa, Prevalence of Retinal Disease, by Country

Exhibit 5-1: Healthcare Expenditure by Country
Exhibit 5-2: Worldwide Ophthalmic Products Market by Segment, 2006
Exhibit 5-3: Percentage of Refractive Surgery Procedures by Type, Worldwide, 2004-2010
Exhibit 5-4: Manufacturers and Product Offerings in Refractive Surgery
Exhibit 5-5: Shares of Flap-Cutting Procedure Market by Company, 2005 & 2010
Exhibit 5-6: Ophthalmic Pharmaceutical Revenues, by Type, 2008
Exhibit 5-7: U.S. Glaucoma Procdures by Type, 2005
Exhibit 5-8: Phacoemulsification Systems for Cataract Surgery, U.S. and ROW, 2005
Exhibit 5-9: Worldwide Cataract Surgery Market by Product Segment: IOLs, Phaco Equipment and Viscoelastics, 2003-2008
Exhibit 5-10: USA: Diagnostic Instrument Market, 2004-2012
Exhibit 5-11: U.S. Diagnostic Instrument Market Share by Company, 2004-2012
Exhibit 5-12: Non-USA Americas, Diagnostic Instrument Market, 2004-2012
Exhibit 5-13: Non-USA Americas: Diagnostic Instrument Market Share by Company
Exhibit 5-14: United Kingdom, Diagnostic Instrument Market, 2004-2012
Exhibit 5-15: United Kingdom, Ophthalmic Diagnostic Instrument Market Share by Company, 2004-2012
Exhibit 5-16: Germany, Diagnostic Instrument Market, 2004-2012
Exhibit 5-17: Germany, Diagnostic Market Share by Company, 2004-2012
Exhibit 5-18: France, Ophthalmic Diagnostic Market Share by Company, 2004-2012
Exhibit 5-19: BeNeLux, Ophthalmic Diagnostic Instrument Market, 2004-2012
Exhibit 5-20: BeNeLux, Diagnostic Market Share by Company, 2004-2012
Exhibit 5-21: Italy, Diagnostic Instrument Market, 2004-2012
Exhibit 5-22: Italy, Diagnostic Market Share by Company, 2004-2012
Exhibit 5-23: Spain, Diagnostic Instrument Market, 2004-2012
Exhibit 5-24: Spain, Diagnostic Market Share by Company, 2004-2012
Exhibit 5-25: Europe, Diagnostic Instrument Market, 2004-2012
Exhibit 5-26: Japan, Diagnostic Instrument Market, 2004-2012
Exhibit 5-27: Japan, Diagnostic Market Share (%) by Company, 2004-2012
Exhibit 5-28: Non-Japan Asia-Pacific, Ophthalmic Diagnostic Instrument Market, 2004-2012
Exhibit 5-29: Non-Japan Asia-Pacific, Diagnostic Market Share by Company, 2004-2012
Exhibit 5-30: Total Asia Pacific, Diagnostic Instrument Market ($000s), 2004-2012
Exhibit 5-31: Worldwide Ophthalmic Diagnostic Instrument Market ($000s) by Company, 2004-2012
Exhibit 5-32: USA Cataract Surgery Market, 2004-2012
Exhibit 5-33: U.S. Cataract Surgery Market Share by Company, 2004-2012
Exhibit 5-34: Non-USA Americas, Cataract Surgery Market, 2004-2012
Exhibit 5-35: Non-USA Americas: Cataract Surgery Market Share (%) by Company, 2004-2012
Exhibit 5-36: Americas, Total Cataract Surgery Market by Company, 2004-2012
Exhibit 5-37: Total Americas Cataract Surgery Market, 2004-2012
Exhibit 5-38: United Kingdom, Cataract Surgery Market, 2004-2012
Exhibit 5-39: United Kingdom, Cataract Surgery Market Share by Company, 2004-2012
Exhibit 5-40: Germany Cataract Surgery Market, 2004-2012
Exhibit 5-41: Germany, Cataract Surgery Market Share by Company
Exhibit 5-42: France, Cataract Surgery Market, 2004-2012
Exhibit 5-43: France, Cataract Surgery Market Share by Company, 2004-2012
Exhibit 5-44: BeNeLux, Cataract Surgery Market, 2004-2012
Exhibit 5-45: BeNeLux, Cataract Surgery Market Share by Company, 2004-2012
Exhibit 5-46: Italy, Cataract Surgery Market, 2004-2012
Exhibit 5-47: Italy, Cataract Surgery Market Share by Company, 2004-2012
Exhibit 5-48: Spain, Cataract Surgery Market, 2004-2012
Exhibit 5-49: Spain, Cataract Surgery Market Share by Company, 2004-2012
Exhibit 5-50: Europe, Cataract Surgery Product Revenues by Company, 2004-2012
Exhibit 5-51: European Revenue Trends for Cataract Surgery Companies, 2004-2012
Exhibit 5-52: Japan, Cataract Surgery Market, 2004-2012
Exhibit 5-53: Japan, Cataract Surgery Market Share by Company, 2004-2012
Exhibit 5-54: Non-Japan Asia-Pacific, Cataract Surgery Market, 2004-2012
Exhibit 5-55: Non-Japan Asia-Pacific, Cataract Surgery Market Share by Company, 2004-2012
Exhibit 5-56: Total Asia-Pacific, Cataract Surgery Market Revenues by Company, 2004-2012
Exhibit 5-57: Worldwide Cataract Surgery Market by Company, 2004-2012
Exhibit 5-58: U.S. Refractive Surgery Market, 2004-2012
Exhibit 5-59: U.S. Refractive Surgery Market Share (%) by Company, 2004-2012
Exhibit 5-60: Non-USA Americas, Refractive Surgery Market, 2004-2012
Exhibit 5-61: Non-USA Americas, Refractive Surgery Market Share by Company, 2004-2012
Exhibit 5-62: Americas, Total Refractive Surgery Revenues ($000s), by Company, 2004-2012
Exhibit 5-63: United Kingdom, Refractive Surgery Market, 2004-2012
Exhibit 5-64: United Kingdom, Refractive Surgery Market Share by Company, 2004-2012
Exhibit 5-65: Germany, Refractive Surgery Market, 2004-2012
Exhibit 5-66: Germany, Refractive Surgery Market Share by Company, 2004-2012
Exhibit 5-67: France, Refractive Surgery Market, 2004-2012
Exhibit 5-68: France, Refractive Surgery Market Share by Company, 2004-2012
Exhibit 5-69: BeNeLux, Refractive Surgery Market, 2004-2012
Exhibit 5-70: BeNeLux, Refractive Surgery Market Share by Company, 2004-2012
Exhibit 5-71: Italy, Refractive Surgery Market, 2004-2012
Exhibit 5-72: Italy, Refractive Surgery Market Share by Company, 2004-2012
Exhibit 5-73: Spain, Refractive Surgery Market, 2004-2012
Exhibit 5-74: Spain, Refractive Surgery Market Share by Company, 2004-2012
Exhibit 5-75: Europe, Refractive Surgery Market by Company, 2004-2012
Exhibit 5-76: Japan, Refractive Surgery Market by Company, 2004-2012
Exhibit 5-77: Japan, Refractive Market Share by Company, 2004-2012
Exhibit 5-78: Non-Japan Asia-Pacific, Refractive Surgery Market by Country
Exhibit 5-79: Non-Japan Asia-Pacific, Refractive Surgery Market by Company
Exhibit 5-80: Total Asia Pacific Refractive Market by Company, 2004-2012
Exhibit 5-81: Worldwide Refractive Surgery Market by Company, 2004-2012
Exhibit 5-82: Leading Suppliers of Dry Eye Products and Annual Dry Eye Product Sales
Exhibit 5-83: Worldwide Ophthalmic Pharmaceutical Sales by Supplier
Exhibit 5-84: U.S. Ophthalmic Drug Revenue Shares by Supplier, 2003-2010
Exhibit 5-85: U.S. Ophthalmic Pharmaceutical Market, 2004-2012
Exhibit 5-86: U.S. Ophthalmic Pharmaceutical Market Share) by Company, 2004-2012
Exhibit 5-87: U.S. Ophthalmic Pharmaceutical Market by Segment, 2004-2012
Exhibit 5-88: Non-USA Americas, Ophthalmic Pharmaceutical Market, 2004-2012
Exhibit 5-89: Non-USA Americas, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
Exhibit 5-90: Non-USA Americas, Ophthalmic Pharmaceutical Market by Segment, 2004-2012
Exhibit 5-91: Total Americas, Ophthalmic Pharmaceutical Market by Segment, 2004-2012
Exhibit 5-92: United Kingdom, Ophthalmic Pharmaceutical Market, 2004-2012
Exhibit 5-93: United Kingdom, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
Exhibit 5-94: Germany, Ophthalmic Pharmaceutical Market, 2004-2012
Exhibit 5-95: Germany, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
Exhibit 5-96: France, Diagnostic Instrument Market, 2004-2012
Exhibit 5-97: France, Ophthalmic Pharmaceutical Market, 2004-2012
Exhibit 5-98: France, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
Exhibit 5-99: BeNeLux, Ophthalmic Pharmaceutical Market, 2004-2012
Exhibit 5-100: BeNeLux, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
Exhibit 5-101: Italy, Ophthalmic Pharmaceutical Market, 2004-2012
Exhibit 5-102: Italy, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
Exhibit 5-103: Spain, Ophthalmic Pharmaceutical Market, 2004-2012
Exhibit 5-104: Spain, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
Exhibit 5-105: Europe, Ophthalmic Pharmaceutical Market by Company, 2004-2012
Exhibit 5-106: Europe, Ophthalmic Pharmaceutical Market by Segment, 2004-2012
Exhibit 5-107: Japan, Ophthalmic Pharmaceutical Market, 2004-2012
Exhibit 5-108: Japan, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
Exhibit 5-109: Non-Japan Asia-Pacific, Ophthalmic Pharmaceutical Market, 2004-2012
Exhibit 5-110: Non-Japan, Asia-Pacific, Ophthalmic Pharmaceutical Market Share by Company, 2004-2012
Exhibit 5-111: Total Asia-Pacific Ophthalmic Pharmaceutical Market ($000s) by Company, 2004-2012
Exhibit 5-112: Total Asia-Pacific Ophthalmic Pharmaceutical Market by Segment, 2004-2012
Exhibit 5-113: Worldwide Ophthalmic Pharmaceutical Market ($millions) by Company, 2004-2012
Exhibit 5-114: Worldwide Ophthalmic Pharmaceutical Market ($000s) by Segment, 2004-2012

Exhibit 6-1: Recent Acquisitions Contributing to the AMO Product Line
Exhibit 6-2: AMO Cataract and Refractive Surgical Brands
Exhibit 6-3: AMO 2005 Revenues by World Region and Product Category ($000s)
Exhibit 6-4: Projected 2006 AMO Sales by Product Line
Exhibit 6-5: Alcon Pharmaceutical & Surgical Products
Exhibit 6-6: Alcon Product Launches Adding to International Pipeline
Exhibit 6-7: Alcon Revenue (Millions), 2003-2006
Exhibit 6-8: 2005 Alcon Revenues by World Region and Product Category ($000s)
Exhibit 6-9: Alcon Projected 2006 Sales by Product Line
Exhibit 6-10: Allergan Pharmaceutical Products by Category
Exhibit 6-11: Net Sales of Allergan Specialty Pharmaceutical Products, 2003-2005
Exhibit 6-12: Net Allergan Sales by Geographic Region, 2003-2005
Exhibit 6-13: Bausch & Lomb 2006 Product Mix by Percentage of Revneues
Exhibit 6-14: B&L Product Brands by Category
Exhibit 6-15: B&L Sales Estimates for 2005 and 2006 by Geographic Region
Exhibit 6-16: The new Carl Zeiss Meditec after CZSurgical acquisition
Exhibit 6-17: Breakdown of Carl Zeiss Meditec' s Business by Revenue and Business Segment
Exhibit 6-18: Carl Zeiss Meditech Consolidated Sales by Region for FY 2005/2006E
Exhibit 6-19: IntraLase Revenues by Product and Year
Exhibit 6-20: IntraLase Revenues by Geographic Region, 2003-2006
Exhibit 6-21: STAAR Surgical Sales, 2003-2006
Exhibit 6-22: STAAR Revenues by Product Category, 2006
Exhibit 6-23: IRIDEX Ophthalmology Revenues by Geography, 2003-2006
Exhibit 6-24: Growth of IRIDEX International Market Sales, 2003-2006

世界の眼科手術、装置、薬剤市場における製品、技術および機会：2007年

Products, Technologies, Markets and Opportunities in Ophthalmology Surgical, Device and Drug Markets Worldwide, 2007

Abstract

Table of Contents

Section 1: About vision care

Section 2: THE MARKET FOR DIAGNOSTIC INSTRUMENTATION

Section 3: THERAPEUTIC OPTIONS

Section 4: Incidence/Prevalence of Ophthalmic Disorders

Section 5: THE MARKET FOR OPHTHALMOLOGY PRODUCTS

Section 6: Company Profiles

Appendix: Company Addresses